Continuing Medical Education (CME) For Your Healthcare Team

Immune-Related Adverse Events with Cancer Immunotherapy: Case-Based Challenges for the Oncology Nurse
Click here to complete this activity
Precision Therapy in NSCLC: Pharmacist Perspectives on Testing Strategies and Biomarker-driven Treatment Approaches
For more information on this program click here
Pharmacist Perspectives: Exploring the Evolving Role of BTK Inhibitors in CLL
For more information on this program click here
Navigating a Changing Landscape in TNBC: Pharmacist-Focused Strategies in the Era of Immunotherapy
For more information on this program click here
New Horizons in HER2+ Breast Cancer: Pharmacist-Focused Strategies and Insights
For more information on this program click here
A New Frontier in Cancer Therapy: Examining the Role of PARP Inhibitors in an Emerging Paradigm
Complete Activity
Exploiting Deficiencies in the Tumor Genome: Expert Perspectives in the Era of PARP Inhibitors
Complete Activity
The Changing Face of Lung Cancer: Exploring Recent Advances in Precision Medicine for EGFR-Mutated NSCLC
Complete Activity
Immune-Related Adverse Events with Cancer Immunotherapy: Case-Based Challenges for the Oncology Nurse
For more information on the regional chapter series click here
EGFR Resisters Inaugural Think Tank Proceedings and Call to Action
To read the proceedings and call to action click here
The Changing Face of Lung Cancer: Exploring Recent Advances in Precision Medicine for EGFR-Mutated NSCLC
For more information on the regional chapter series click here
B-Cell Malignancies Tumor Board: Therapeutic Decision Making in Challenging Clinical Scenarios (Regional Chapters)
For more information on regional chapters click here
Expert Perspectives in The Era of PARP Inhibitors: Practical Applications for Your Ovarian Cancer Patients
For more information on the multi-modal grand rounds click here

HomeSpiderSavvy2018-09-18T12:08:25-04:00

Upcoming Events

Exploiting Deficiencies in the Tumor Genome: Expert Perspectives in the Era of PARP Inhibitors

May 31, 2019 - May 31, 2020

A New Frontier in Cancer Therapy: Examining the Role of PARP Inhibitors in an Emerging Paradigm

June 17, 2019 - June 17, 2020

The Changing Face of Lung Cancer: Exploring Recent Advances in Precision Medicine for EGFR-Mutated NSCLC

July 31, 2019 - July 31, 2020

Expert Perspectives in The Era of PARP Inhibitors: Practical Applications for Your Ovarian Cancer Patients

February 27

Immune-Related Adverse Events with Cancer Immunotherapy: Case-Based Challenges for the Oncology Nurse

Precision Therapy in NSCLC: Pharmacist Perspectives on Testing Strategies and Biomarker-driven Treatment Approaches

Pharmacist Perspectives: Exploring the Evolving Role of BTK Inhibitors in CLL

Navigating a Changing Landscape in TNBC: Pharmacist-Focused Strategies in the Era of Immunotherapy

New Horizons in HER2+ Breast Cancer: Pharmacist-Focused Strategies and Insights

A New Frontier in Cancer Therapy: Examining the Role of PARP Inhibitors in an Emerging Paradigm

Exploiting Deficiencies in the Tumor Genome: Expert Perspectives in the Era of PARP Inhibitors

The Changing Face of Lung Cancer: Exploring Recent Advances in Precision Medicine for EGFR-Mutated NSCLC

Immune-Related Adverse Events with Cancer Immunotherapy: Case-Based Challenges for the Oncology Nurse

EGFR Resisters Inaugural Think Tank Proceedings and Call to Action

The Changing Face of Lung Cancer: Exploring Recent Advances in Precision Medicine for EGFR-Mutated NSCLC

B-Cell Malignancies Tumor Board: Therapeutic Decision Making in Challenging Clinical Scenarios (Regional Chapters)

Expert Perspectives in The Era of PARP Inhibitors: Practical Applications for Your Ovarian Cancer Patients

Upcoming Events

Exploiting Deficiencies in the Tumor Genome: Expert Perspectives in the Era of PARP Inhibitors

May 31, 2019 - May 31, 2020

A New Frontier in Cancer Therapy: Examining the Role of PARP Inhibitors in an Emerging Paradigm

June 17, 2019 - June 17, 2020

The Changing Face of Lung Cancer: Exploring Recent Advances in Precision Medicine for EGFR-Mutated NSCLC

July 31, 2019 - July 31, 2020

Expert Perspectives in The Era of PARP Inhibitors: Practical Applications for Your Ovarian Cancer Patients

February 27